Kestra Medical Technologies (KMTS) Financial Ratios

For fiscal 2026 (fiscal year ended Apr 30, 2026), Kestra Medical Technologies had return on equity of -56.6% (up from -131.5%), debt-to-equity of 0.18 (down from 0.22), a current ratio of 4.41 (down from 6.72) and return on assets of -25.7% (up from -38.9%). A current ratio of 4.41 means current assets exceed current liabilities.

Kestra Medical Technologies Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021	FY 2019
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2021	Apr 2020
Valuation Ratios
P/S Ratio	12.71	20.65	-	-	-	-
P/B Ratio	4.66	6.01	-	-	-	-
Price/Tangible Book	4.66	6.01	-	-	-	-
Enterprise Value Ratios
EV/Revenue	10.14	25.48	-	-	-	-
Profitability & Returns
Return on Equity (ROE)	-56.60%	-131.47%	-	-	-1212.91%	-763.99%
Return on Assets (ROA)	-25.74%	-38.92%	-125.68%	-	-106.48%	-374.28%
Return on Invested Capital (ROIC)	-	-	-	-	8080.68%	2036.42%
Return on Capital Employed (ROCE)	-43.70%	-41.30%	-655.40%	-4195.10%	-136.80%	-760.15%
Leverage & Solvency Ratios
Debt/Equity	0.18	0.22	-1.40	-2.53	12.94	0.00
Debt/EBITDA	-	-	-	-	-0.71	-0.02
Debt/FCF	-	-	-	-	-0.76	-0.01
Liquidity Ratios
Current Ratio	4.41	6.72	0.45	0.50	3.96	1.54
Quick Ratio	4.19	6.47	0.31	0.40	3.68	1.43
Efficiency Ratios
Asset Turnover	0.29	0.35	0.66	-	0.00	0.00
Inventory Turnover	6.97	7.22	10.16	-	-	-
Yield & Distribution Ratios
Earnings Yield	-10.88%	-9.21%	-	-	-	-
FCF Yield	-9.68%	-8.19%	-	-	-	-
Buyback Yield	-120.41%	-23.63%	-18693.84%	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Kestra Medical Technologies Financial Ratios

What is Kestra Medical Technologies's return on equity?

Kestra Medical Technologies's return on equity (ROE) was -56.6% for fiscal 2026 (period ended Apr 30, 2026). It was -131.5% a year earlier.

What is Kestra Medical Technologies's debt-to-equity ratio?

Kestra Medical Technologies's debt-to-equity ratio was 0.18 for fiscal 2026 (period ended Apr 30, 2026). It was 0.22 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition